3 results
Not approvedWill not start
The primary objective of this study is to evaluate the proportion of patients achieving FXI inhibition * 80% at trough (Day 91) after monthly dosing at 3 dose levels of MAA868.
Approved WMORecruiting
The primary objective of the UNLOAD-CHIP is to investigate the combined clinical endpoint (as described in primary and secundary endpoints).
Approved WMORecruiting
The primary objective is to test the feasibility of daily adaptive radiotherapy plan based on the cone beam CT. The expectance is that this new technique will make the radiotherapy more precise which results in less side effects or patient could…